Health alert Status: Active Date issued: 19 June 2026 Issued by: Dr Caroline McElnay, Chief Health Officer Issued to: Health professionals and the Victorian community Key messages The department has been notified of six cases of acute liver toxicity associated with an unapproved peptide product in Australia, labelled Retatrutide
Epimedii Herba), was found to attenuate the progression of CKD and the loss of structural and functional integrity of kidney tissue, as evidenced by reduced serum levels of uric acid, creatinine, and blood urea nitrogen (Figure 1) The active ingredient of Ginseng, ginsenoside-Rd, has been found to protect against renal failure induced by cisplatin administration through a reduction in oxidative stress and an inhibition of DNA fragmentation ( Astragalus propinquus Schischkin (Leguminosae), was found to improve renal function and fibrosis by inhibiting miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice
At week 8, he was back playing in non-contact drills, and by week 10 he was back in full competition, pain free
This is the first of seven peptides the committee is reviewing and there are additional discussions and votes expected Thursday and Friday
